All News

Body Image and Sexual Health Challenges After Breast Cancer

October 9th 2025, 8:00pm

Article

Young women with breast cancer experience significant declines in body image, sexual satisfaction, and sexual interest both during and after treatment.

What Libtayo Means for High-Risk Cutaneous Squamous Cell Carcinoma

October 9th 2025, 7:00pm

Article

Dr. Vishal Patel explains what Libtayo’s FDA approval means for patients with high-risk cutaneous squamous cell carcinoma.

Breast Cancer Awareness Needs Action, Not Just Pink Ribbons

October 9th 2025, 5:00pm

Article

As a survivor, I see pink ribbons everywhere, but what we really need is more research, better treatments, and real change for those living with cancer.

What Are Non-Muscle Invasive Bladder Cancer and its Treatment Options?

October 9th 2025, 3:59pm

Article

Dr. Patrick J. Hensley explains non-muscle invasive bladder cancer, bladder-preserving treatments, trial eligibility, novel therapies and research priorities for patients.

FDA Grants Fast Tract Designation to VT3989 for Mesothelioma

October 9th 2025, 3:00pm

Article

The FDA granted fast track designation to VT3989 for unresectable malignant nonpleural or pleural mesotherlioma.

Minimally Invasive Kidney Cancer Treatments Boosts Patient Recovery

October 9th 2025, 1:00pm

Video

Dr. Ravi Munver highlights how minimally invasive treatment has improved recovery and quality, improving outcomes for patients with kidney cancer

How Can Remote Monitoring Help Patients After Cancer Surgery?

October 8th 2025, 9:00pm

Article

Remote monitoring has been found to be associated with improved postsurgical recovery for patients with cancer.

Reiki Therapy Evaluated to Ease Stress During Breast Cancer Surgery

October 8th 2025, 8:00pm

Video

Dr. Sheldon Marc Feldman explores Reiki’s potential to reduce stress and anxiety for patients undergoing breast cancer surgery at Montefiore Einstein Comprehensive Cancer Center.

FDA Approves Libtayo for Cutaneous Squamous Cell Carcinoma Treatment

October 8th 2025, 7:04pm

Article

The FDA has approved Libtayo for the postsurgical treatment of adults with cutaneous squamous cell carcinoma.

What Standing Up to Colon Cancer Means to Me

October 8th 2025, 5:00pm

Article

At the age of 34, I received the biggest news of my life, which was my diagnosis with colon cancer. I remember that day like it was yesterday.